OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates

Core Insights - OraSure Technologies reported a quarterly loss of $0.13 per share, which was better than the Zacks Consensus Estimate of a loss of $0.16, representing an earnings surprise of +18.75% [1] - The company posted revenues of $27.09 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 7.05% and down from $39.92 million year-over-year [2] - OraSure shares have declined approximately 28.8% year-to-date, contrasting with the S&P 500's gain of 15.1% [3] Financial Performance - Over the last four quarters, OraSure has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.15 on revenues of $31.22 million, and for the current fiscal year, it is -$0.67 on revenues of $121.53 million [7] Market Outlook - The company's stock is currently rated Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] - The Medical - Products industry, to which OraSure belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, which may negatively impact stock performance [8]